We here reveal that NLGN1 is decreased in the hippocampus of patients with prodromal signs of and established neurodegeneration in a symptomatology-dependent manner and, using in vitro and in vivo models, that this change is likely driven, at least in part, by Aβo and contributing to cognitive decline. This evidence concerns the gene ABO and Mental deterioration.